black box warning semaglutide These highlights do not include all the information needed to use OZEMPIC® safely and effectively. See full prescribing information for OZEMPIC. OZEMPIC (semaglutide) injection, for subcutaneous use Initial U.S. Approval: 2017 US FDA removes suicidal thoughts

Injectable semaglutide is administered directly into the tissue under the skin, allowing for slow, consistent absorption throughout the week

Maintenance strategy The goal is durable weight loss

Therefore, it is recommended to start the medication at a very low dose (1 mg or 2 mg) to help your body adjust, improve tolerance, and reduce the risk of side effects

November 22 Product: BridgeBios Attruby Indication: Transthyretin amyloid cardiomyopathy Thanksgiving came early for BridgeBioand transthyretin amyloid cardiomyopathy (ATTR-CM) patientsafter the FDA approved the companys Attruby a week before its scheduled PDUFA date

| 03.21.25 | 9 min read